FINWIRES · TerminalLIVE
FINWIRES

GEベローナとパーカー・ハニフィンは、産業需要の改善から恩恵を受ける見込みだとバンク・オブ・アメリカが指摘

-- バンク・オブ・アメリカ証券は月曜日のレポートで、GE Vernova(GEV)、パーカー・ハニフィン(PH)、アメテック(AME)などが、受注動向の強化と防衛関連事業の拡大による追加的な追い風を受け、短期サイクル産業需要の改善から恩恵を受けると予想される企業に含まれると述べた。 バンク・オブ・アメリカは、データセンター需要と日米貿易協定に基づくオハイオ州発電プロジェクトによる潜在的な上振れを背景に、GE Vernovaの受注が今年44%増加すると予想している。防衛関連事業はパーカー・ハニフィンの売上高の11%、アメテックとITT(ITT)の売上高のそれぞれ10%を占めている、とレポートは指摘している。 3M(MMM)とフォージェント・パワー・ソリューションズ(FPS)は、S&P500指数の最近の1%下落に追いつかず出遅れている一方、Vertiv(VRT)、GE Vernova、Fastenal(FAST)は好調に推移している、とレポートは述べている。 消費者支出に密接に関係する企業はより大きなプレッシャーに直面する可能性がある一方、産業部品サプライヤーは第4四半期に受注が回復したことで収益成長が最も大きく改善する見込みだと、同レポートは述べている。バンク・オブ・アメリカは、中東紛争に関連したサプライチェーンの混乱が第2四半期の出荷時期に影響を与える可能性があると指摘した。

Price: $990.82, Change: $-0.50, Percent Change: -0.05%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB